Acurx Pharmaceuticals Files 2024 10-K, Reports Capital Activities
Ticker: ACXP · Form: 10-K · Filed: Mar 17, 2025 · CIK: 1736243
Sentiment: neutral
Topics: 10-K, pharmaceuticals, capital-raising, financials
TL;DR
ACXP 2024 10-K filed. Capital raised via offerings. Subsequent financing in Jan 2025.
AI Summary
Acurx Pharmaceuticals, Inc. filed its 2024 10-K on March 17, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company's fiscal year saw significant activity in its capital structure, including an At-Market Offering and a Registered Direct Offering. Acurx Pharmaceuticals also disclosed a Registered Direct and Private Placement that occurred on January 6, 2025, involving affiliate investors.
Why It Matters
This filing provides investors with a comprehensive overview of Acurx Pharmaceuticals' financial health and strategic capital-raising activities over the past year, which can influence future growth and operations.
Risk Assessment
Risk Level: medium — The company's financial disclosures, including capital-raising activities, suggest ongoing financial operations that may carry inherent risks typical of pharmaceutical development companies.
Key Numbers
- 17030686 — Total Assets (Reported for fiscal year 2024)
- 16163366 — Total Liabilities (Reported for fiscal year 2024)
- 12671572 — Total Equity (Reported for fiscal year 2024)
Key Players & Entities
- Acurx Pharmaceuticals, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-17 (date) — Filing date
- 259 Liberty Avenue, Staten Island, NY 10305 (address) — Business and Mail Address
- 2025-01-06 (date) — Date of Registered Direct and Private Placement
FAQ
What were the primary capital-raising activities of Acurx Pharmaceuticals in 2024?
Acurx Pharmaceuticals engaged in an 'AtMarketOfferingMember' and a 'RegisteredDirectOfferingMember' as indicated in the filing for the period of 2024-01-01 to 2024-12-31.
When did the Registered Direct and Private Placement involving affiliate investors occur?
The Registered Direct and Private Placement involving affiliate investors occurred on January 6, 2025.
What is Acurx Pharmaceuticals' Standard Industrial Classification (SIC) code?
Acurx Pharmaceuticals' SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What was the company's fiscal year end for this 10-K filing?
The fiscal year end for this 10-K filing was December 31, 2024.
What is the company's SEC file number?
The SEC file number for Acurx Pharmaceuticals, Inc. is 001-40536.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 17, 2025 regarding Acurx Pharmaceuticals, Inc. (ACXP).